These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22391630)
41. Analysis of the structure and surfactant activity of novel formulations containing exogenous pulmonary surfactant and glucocorticoids. Cimato A; Hoyos Obando A; Facorro G; Martínez Sarrasague M Respir Physiol Neurobiol; 2016 Nov; 233():33-40. PubMed ID: 27476933 [TBL] [Abstract][Full Text] [Related]
42. Atomic Force Microscopy Imaging of Adsorbed Pulmonary Surfactant Films. Xu L; Yang Y; Zuo YY Biophys J; 2020 Aug; 119(4):756-766. PubMed ID: 32702292 [TBL] [Abstract][Full Text] [Related]
43. Dynamic surface activity of films of lung surfactant phospholipids, hydrophobic proteins, and neutral lipids. Wang Z; Hall SB; Notter RH J Lipid Res; 1995 Jun; 36(6):1283-93. PubMed ID: 7666006 [TBL] [Abstract][Full Text] [Related]
44. Cholesterol rules: direct observation of the coexistence of two fluid phases in native pulmonary surfactant membranes at physiological temperatures. Bernardino de la Serna J; Perez-Gil J; Simonsen AC; Bagatolli LA J Biol Chem; 2004 Sep; 279(39):40715-22. PubMed ID: 15231828 [TBL] [Abstract][Full Text] [Related]
45. Effect of serum, cholesterol and low density lipoprotein on the functionality and structure of lung surfactant films. Nahak P; Nag K; Hillier A; Devraj R; Thompson DW; Manna K; Makino K; Ohshima H; Nakahara H; Shibata O; Panda AK J Oleo Sci; 2014; 63(12):1333-49. PubMed ID: 25409691 [TBL] [Abstract][Full Text] [Related]
46. Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant. Fan Q; Wang YE; Zhao X; Loo JS; Zuo YY ACS Nano; 2011 Aug; 5(8):6410-6. PubMed ID: 21761867 [TBL] [Abstract][Full Text] [Related]
47. Note: dissolution of aerosol particles of budesonide in Survanta, a model lung surfactant. Pham S; Wiedmann TS J Pharm Sci; 2001 Jan; 90(1):98-104. PubMed ID: 11064383 [TBL] [Abstract][Full Text] [Related]
49. Interfacial behavior and structural properties of a clinical lung surfactant from porcine source. Blanco O; Cruz A; Ospina OL; López-Rodriguez E; Vázquez L; Pérez-Gil J Biochim Biophys Acta; 2012 Nov; 1818(11):2756-66. PubMed ID: 22771553 [TBL] [Abstract][Full Text] [Related]
50. Natural Derived Surfactant Preparation As a Carrier of Polymyxin E for Treatment of Pseudomonas aeruginosa Pneumonia in a Near-Term Rabbit Model. Basabe-Burgos O; Zebialowicz J; Stichtenoth G; Curstedt T; Bergman P; Johansson J; Rising A J Aerosol Med Pulm Drug Deliv; 2019 Apr; 32(2):110-118. PubMed ID: 30339061 [TBL] [Abstract][Full Text] [Related]
51. Effects of lung surfactant proteins, SP-B and SP-C, and palmitic acid on monolayer stability. Ding J; Takamoto DY; von Nahmen A; Lipp MM; Lee KY; Waring AJ; Zasadzinski JA Biophys J; 2001 May; 80(5):2262-72. PubMed ID: 11325728 [TBL] [Abstract][Full Text] [Related]
52. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury. Mikolka P; Kopincova J; Tomcikova Mikusiakova L; Kosutova P; Antosova M; Calkovska A; Mokra D J Physiol Pharmacol; 2016 Feb; 67(1):57-65. PubMed ID: 27010895 [TBL] [Abstract][Full Text] [Related]
53. The role of multilayers in preventing the premature buckling of the pulmonary surfactant. Al-Saiedy M; Tarokh A; Nelson S; Hossini K; Green F; Ling CC; Prenner EJ; Amrein M Biochim Biophys Acta Biomembr; 2017 Aug; 1859(8):1372-1380. PubMed ID: 28501605 [TBL] [Abstract][Full Text] [Related]
54. Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran. Ochs M; Schüttler M; Stichtenoth G; Herting E Respir Res; 2006 Jun; 7(1):86. PubMed ID: 16756655 [TBL] [Abstract][Full Text] [Related]
56. Monolayer-multilayer transitions in a lung surfactant model: IR reflection-absorption spectroscopy and atomic force microscopy. Wang L; Cai P; Galla HJ; He H; Flach CR; Mendelsohn R Eur Biophys J; 2005 May; 34(3):243-54. PubMed ID: 15645307 [TBL] [Abstract][Full Text] [Related]
57. Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant. Keating E; Rahman L; Francis J; Petersen A; Possmayer F; Veldhuizen R; Petersen NO Biophys J; 2007 Aug; 93(4):1391-401. PubMed ID: 17526587 [TBL] [Abstract][Full Text] [Related]
58. Dipalmitoylphosphatidylcholine and cholesterol in monolayers spread from adsorbed films of pulmonary surfactant. Yu SH; Possmayer F J Lipid Res; 2001 Sep; 42(9):1421-9. PubMed ID: 11518761 [TBL] [Abstract][Full Text] [Related]